Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial

« Previous Next »Urology
Volume 54, Issue 6 , Pages 960-963, December 1999

Daniel A Shoskes
- Institute for Male Urology, Encino, California, USA
- Division of Urology, Harbor-UCLA Medical Center, University of California, Los Angeles, School of Medicine, Torrance, California, USA
- D. A. Shoskes and J. Rajfer own stock in companies that will benefit from sales of the supplements reported in this study.
- Reprint requests: Daniel A. Shoskes, M.D., Division of Urology, Harbor-UCLA Medical Center, Box 5, 1000 West Carson Street, Torrance, CA 90502
Scott I Zeitlin
- Institute for Male Urology, Encino, California, USA
- Division of Urology, Harbor-UCLA Medical Center, University of California, Los Angeles, School of Medicine, Torrance, California, USA
Asha Shahed
- Division of Urology, Harbor-UCLA Medical Center, University of California, Los Angeles, School of Medicine, Torrance, California, USA
Jacob Rajfer
- Institute for Male Urology, Encino, California, USA
- Division of Urology, Harbor-UCLA Medical Center, University of California, Los Angeles, School of Medicine, Torrance, California, USA